Bruce G. Allen Investments’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-45
Closed -$4.57K 1106
2025
Q4
$4.57K Hold
45
﹤0.01% 575
2025
Q3
$2.46K Hold
45
﹤0.01% 672
2025
Q2
$2.39K Hold
45
﹤0.01% 679
2025
Q1
$1.95K Hold
45
﹤0.01% 710
2024
Q4
$2.53K Hold
45
﹤0.01% 670
2024
Q3
$3.06K Hold
45
﹤0.01% 650
2024
Q2
$1.9K Sell
45
-10
-18% -$550 ﹤0.01% 689
2024
Q1
$3.8K Buy
55
+16
+41% +$1.01K ﹤0.01% 629
2023
Q4
$2.88K Buy
+39
New +$2.56K ﹤0.01% 686

Other funds holding EXAS

Bruce G. Allen Investments's EXAS Position: Q1 2026 in Review

Bruce G. Allen Investments sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 45 shares — an estimated $4.57K sold.

Bruce G. Allen Investments first reported a position in EXAS in Q4 2023 and held it in 9 quarters. The position peaked at $4.57K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Bruce G. Allen Investments reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Bruce G. Allen Investments sold 45 Exact Sciences shares in Q1 2026, an estimated $4.57K.
  • Bruce G. Allen Investments first reported a position in Exact Sciences in Q4 2023 and held it in 9 quarters.
  • Bruce G. Allen Investments's Exact Sciences position peaked at $4.57K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Bruce G. Allen Investments's 13F filing for Q1 2026, filed 8 May 2026.